Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia.

Mar-Heyming R, Miyazaki M, Weissglas-Volkov D, Kolaitis NA, Sadaat N, Plaisier C, Pajukanta P, Cantor RM, de Bruin TW, Ntambi JM, Lusis AJ.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1193-9. doi: 10.1161/ATVBAHA.107.160150. Epub 2008 Mar 13.

2.

Endurance training-induced accumulation of muscle triglycerides is coupled to upregulation of stearoyl-CoA desaturase 1.

Dobrzyn P, Pyrkowska A, Jazurek M, Szymanski K, Langfort J, Dobrzyn A.

J Appl Physiol (1985). 2010 Dec;109(6):1653-61. doi: 10.1152/japplphysiol.00598.2010. Epub 2010 Sep 16.

3.

Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells.

Yee JK, Mao CS, Hummel HS, Lim S, Sugano S, Rehan VK, Xiao G, Lee WN.

J Lipid Res. 2008 Oct;49(10):2124-34. doi: 10.1194/jlr.M700600-JLR200. Epub 2008 Jul 3.

4.

Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.

Mai K, Andres J, Bobbert T, Assmann A, Biedasek K, Diederich S, Graham I, Larson TR, Pfeiffer AF, Spranger J.

Metabolism. 2012 Jan;61(1):108-16. doi: 10.1016/j.metabol.2011.05.018. Epub 2011 Jul 7.

PMID:
21741058
5.

Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels.

Hofacer R, Magrisso IJ, Jandacek R, Rider T, Tso P, Benoit SC, McNamara RK.

Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):71-7. doi: 10.1016/j.plefa.2011.10.003. Epub 2011 Nov 1.

6.

Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.

Eurlings PM, van der Kallen CJ, Vermeulen VM, de Bruin TW.

Mol Genet Metab. 2003 Nov;80(3):296-301.

PMID:
14680975
7.

Caution on the interpretation of plasma fatty acid composition as a proxy marker for SCD1 activity: particular implications for using the 16:1/16:0 ratio in QTL studies involving hyperlipidemic patients.

Karpe F, Hodson L.

Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):e152; author reply e153. doi: 10.1161/ATVBAHA.108.167718. No abstract available.

8.

Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.

Miyazaki M, Dobrzyn A, Sampath H, Lee SH, Man WC, Chu K, Peters JM, Gonzalez FJ, Ntambi JM.

J Biol Chem. 2004 Aug 13;279(33):35017-24. Epub 2004 Jun 4.

9.

Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.

Aouizerat BE, Allayee H, Cantor RM, Dallinga-Thie GM, Lanning CD, de Bruin TW, Lusis AJ, Rotter JI.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2730-6.

10.

Peroxisome proliferator-activated receptor-γ stimulates the synthesis of monounsaturated fatty acids in dairy goat mammary epithelial cells via the control of stearoyl-coenzyme A desaturase.

Shi HB, Luo J, Yao DW, Zhu JJ, Xu HF, Shi HP, Loor JJ.

J Dairy Sci. 2013;96(12):7844-53. doi: 10.3168/jds.2013-7105. Epub 2013 Oct 11.

PMID:
24119817
11.

Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.

Dobrzyń A, Dobrzyń P.

J Physiol Pharmacol. 2006 Nov;57 Suppl 10:31-42. Review.

PMID:
17242489
12.

Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.

Dobrzyn P, Sampath H, Dobrzyn A, Miyazaki M, Ntambi JM.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E357-64. Epub 2007 Nov 27.

13.

Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.

Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Königsrainer A, Königsrainer I, Häring HU, Schleicher E.

Clin Chem. 2009 Dec;55(12):2113-20. doi: 10.1373/clinchem.2009.127274. Epub 2009 Oct 22.

15.

Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation.

Stryjecki C, Roke K, Clarke S, Nielsen D, Badawi A, El-Sohemy A, Ma DW, Mutch DM.

Mol Genet Metab. 2012 Mar;105(3):421-7. doi: 10.1016/j.ymgme.2011.12.003. Epub 2011 Dec 13.

PMID:
22209225
16.

Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells.

Christianson JL, Nicoloro S, Straubhaar J, Czech MP.

J Biol Chem. 2008 Feb 1;283(5):2906-16. Epub 2007 Nov 21.

17.

Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.

Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM.

J Lipid Res. 2002 Nov;43(11):1899-907.

18.

The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk.

Chajès V, Joulin V, Clavel-Chapelon F.

Curr Opin Lipidol. 2011 Feb;22(1):6-10. doi: 10.1097/MOL.0b013e3283404552. Review.

PMID:
20935562
19.

Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.

Geurts JM, Janssen RG, van Greevenbroek MM, van der Kallen CJ, Cantor RM, Bu X, Aouizerat BE, Allayee H, Rotter JI, de Bruin TW.

Hum Mol Genet. 2000 Sep 1;9(14):2067-74.

PMID:
10958645
20.

Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.

Miller CW, Ntambi JM.

Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9443-8.

Supplemental Content

Support Center